Company NeuroOne Medical Technologies Corporation
Equities
NMTC
US64130M2098
Advanced Medical Equipment & Technology
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.12 USD | -0.88% | -1.75% | -29.11% |
Business Summary
Number of employees: 16
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Strip/Grid Products, Stereoelectrocencephalography Products and Electrode Cable Assembly Products
57.3
%
| 0 | 8.1 % | 2 | 57.3 % | +1,040.65% |
Collaborations
42.7
%
| 2 | 91.9 % | 1 | 42.7 % | -25.33% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 2 | 100.0 % | 3 | 100.0 % | +60.73% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Mark Christanson
FOU | Founder | 56 | 19/08/09 |
David Rosa
CEO | Chief Executive Officer | 59 | 19/07/17 |
Ronald McClurg
DFI | Director of Finance/CFO | 65 | 31/12/20 |
Chief Operating Officer | 53 | 11-09 | |
Steven Mertens
CTO | Chief Tech/Sci/R&D Officer | 61 | 14/04/19 |
Chad Wilhelmy
LAW | General Counsel | - | 17/01/22 |
Hijaz Haris
SAM | Sales & Marketing | - | 26/04/21 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Paul Buckman
CHM | Chairman | 68 | 03/08/17 |
Director/Board Member | 63 | 03/08/17 | |
Edward Andrle
BRD | Director/Board Member | 66 | 17/02/20 |
David Rosa
CEO | Chief Executive Officer | 59 | 19/07/17 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 25,930,926 | 22,794,115 ( 87.90 %) | 0 | 87.90 % |
Company contact information
Sector
Sales per Business
1st Jan change | Capi. | |
---|---|---|
-29.11% | 29.3M | |
-12.42% | 19.08B | |
-46.59% | 2.65B | |
+17.50% | 1.87B | |
-0.58% | 1.61B | |
+25.36% | 1.21B | |
-8.67% | 1.02B | |
-21.91% | 905M | |
-4.42% | 716M | |
-17.51% | 682M |
- Stock Market
- Equities
- NMTC Stock
- Company NeuroOne Medical Technologies Corporation